Diabetic kidney disease: A clinical update from Kidney Disease: Improving Global Outcomes

Mark E. Molitch*, Amanda I. Adler, Allan Flyvbjerg, Robert G. Nelson, Wing Yee So, Christoph Wanner, Bertram L. Kasiske, David C. Wheeler, Dick De Zeeuw, Carl E. Mogensen

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

185 Scopus citations


The incidence and prevalence of diabetes mellitus (DM) continue to grow markedly throughout The world, due primarily to The increase in type 2 DM (T2DM). Although improvements in DM and hypertension management have reduced The proportion of diabetic individuals who develop chronic kidney disease (CKD) and progress to end-stage renal disease (ESRD), The sheer increase in people developing DM will have a major impact on dialysis and transplant needs. This KDIGO conference addressed a number of controversial areas in The management of DM patients with CKD, including aspects of screening for CKD with measurements of albuminuria and estimated glomerular filtration rate (eGFR); defining treatment outcomes; glycemic management in both those developing CKD and those with ESRD; hypertension goals and management, including blockers of The renin-angiotensin-aldosterone system; and lipid management.

Original languageEnglish (US)
Pages (from-to)20-30
Number of pages11
JournalKidney international
Issue number1
StatePublished - Jan 3 2015


  • Albuminuria
  • blood pressure
  • diabetic kidney disease
  • glycemic control
  • lipid management

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Diabetic kidney disease: A clinical update from Kidney Disease: Improving Global Outcomes'. Together they form a unique fingerprint.

Cite this